Stroke Clinical Trial
Official title:
Pattern of Use of Direct Oral Anticoagulants in Non-valvular Atrial Fibrillation Patients in UK General Practices
NCT number | NCT03119116 |
Other study ID # | 19330 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | May 15, 2017 |
Est. completion date | April 16, 2019 |
Verified date | April 2020 |
Source | Bayer |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Many people who suffer from irregular heartbeats (atrial fibrillation) which might cause stroke, need to take blood thinners to prevent it. It is important to prescribe the correct dose of blood thinners to the right patients to ensure the treatment works however avoiding complications. In the recent years, new blood thinners have been available; they require less laboratory tests and fewer visits to a doctor compared to older therapies. This study will look at how the general practitioners in the UK prescribe blood thinners according to the instructions given by the product manufacturer. We will use primary care data that is routinely collected by the general practitioners about their patients but without any possibility to identify individual patients. The results will help us to understand the magnitude of deviation from instructions in order to ensure that the patients benefit from the treatment.
Status | Completed |
Enrollment | 31336 |
Est. completion date | April 16, 2019 |
Est. primary completion date | October 16, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - All patients aged >= 18 years with at least one year of enrollment with the primary care practice and one year since first health contact recorded in the database THIN(The Health Improvement Network) or CPRD(Clinical Practice Research Datalink) prior to index prescription date will be included. - Patients with first prescription of DOACs (rivaroxaban, dabigatran, apixaban) during the study period. - Diagnosis NVAF (any time prior index date or within the 2 weeks after the index date) Exclusion Criteria: - Patients having the history of valvular replacement or mitral stenosis (prior to index date or 2 weeks after index-date) - Patients who have any record of being prescribed their index drug prior to the enrolment period or who qualify as members of more than one cohort on the same day. |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Many Locations | Multiple Locations |
Lead Sponsor | Collaborator |
---|---|
Bayer | Janssen Scientific Affairs, LLC |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Demographic Characteristics | Age Sex Smoking status (previous 6 months) Body mass index (previous 6 months) Blood pressure history (previous 12 months) Number of patients that are naïve vs non-naïve For non-naïve: type and duration of anticoagulant used before index date |
6 years | |
Primary | Risk factor categories | C(Congestive heart failure) H(Hypertension)A(Age)D(Diabetes Mellitus)S2(Prior Stroke or TIA) score C(Congestive heart failure) H(Hypertension)A2(Age =75 years)D(Diabetes Mellitus)S2 V(Vascular disease)A(Age 65-74 years)SC(Sex category) H(Hypertension)A(Abnormal renal and liver function)S(Stroke)B(Bleeding)L(Labile INRs)E(Elderly)D(Drugs or alcohol) score INR(International Normalized Ratio) measurement |
6 years | |
Primary | Previous medical history | Acute MI(Myocardial Infarction) Stroke or TIA(Transient Ischemic Attack) Systemic peripheral arterial embolism Coronary artery disease Congestive heart disease Hypertension Diabetes Renal disease (eGFR) or ACR (Albumin/Creatinine Ratio) |
12 months prior to index date | |
Primary | Previous medication history | Anti-arrhythmics Statins Anti-platelets Beta-blockers ACE(Angiotensin-Converting-Enzyme) inhibitors Anti-diabetic agents Non-steroidal anti-inflammatory drugs (NSAIDs) Antacids Histamine receptor antagonists Proton pump inhibitors (PPIs) Disease-modifying anti-rheumatic drugs (DMARDs) Antidepressants Antipsychotic agents Oral contraceptives Hormone replacement therapy (HRT) Strong inhibitors of Cytochrome P450 or P-GP Strong inducers of CYP3A4 |
12 months prior to index date | |
Primary | Previous use of VKA | Warfarin Other Vitamin K antagonist(s) |
Ever prior to index date | |
Primary | Concurrent co-medication | Anti-coagulants Aspirin Clopidogrel Other |
6 years | |
Primary | Daily dose | DOACs(new oral anticoagulants ) for stroke prevention in NVAF(Non valvular Atrial Fibrillation) patients including those with renal impairment | 6 years | |
Primary | Dose posology | DOACs for stroke prevention in NVAF patients including those with renal impairment | 6 years | |
Primary | Naive status and Non-naive status | DOACs for stroke prevention in NVAF patients including those with renal impairment | 6 years | |
Primary | Treatment Duration | DOACs for stroke prevention in NVAF patients including those with renal impairment | 6 years | |
Secondary | Time-trends | Characteristics of first-time use of DOACs in NVAF patients | 6 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
Recruiting |
NCT03869138 -
Alternative Therapies for Improving Physical Function in Individuals With Stroke
|
N/A | |
Completed |
NCT04034069 -
Effects of Priming Intermittent Theta Burst Stimulation on Upper Limb Motor Recovery After Stroke: A Randomized Controlled Trial
|
N/A | |
Completed |
NCT04101695 -
Hemodynamic Response of Anodal Transcranial Direct Current Stimulation Over the Cerebellar Hemisphere in Healthy Subjects
|
N/A | |
Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
Completed |
NCT00391378 -
Cerebral Lesions and Outcome After Cardiac Surgery (CLOCS)
|
N/A | |
Recruiting |
NCT06204744 -
Home-based Arm and Hand Exercise Program for Stroke: A Multisite Trial
|
N/A | |
Active, not recruiting |
NCT06043167 -
Clinimetric Application of FOUR Scale as in Treatment and Rehabilitation of Patients With Acute Cerebral Injury
|
||
Enrolling by invitation |
NCT04535479 -
Dry Needling for Spasticity in Stroke
|
N/A | |
Completed |
NCT03985761 -
Utilizing Gaming Mechanics to Optimize Telerehabilitation Adherence in Persons With Stroke
|
N/A | |
Recruiting |
NCT00859885 -
International PFO Consortium
|
N/A | |
Recruiting |
NCT06034119 -
Effects of Voluntary Adjustments During Walking in Participants Post-stroke
|
N/A | |
Completed |
NCT03622411 -
Tablet-based Aphasia Therapy in the Chronic Phase
|
N/A | |
Completed |
NCT01662960 -
Visual Feedback Therapy for Treating Individuals With Hemiparesis Following Stroke
|
N/A | |
Recruiting |
NCT05854485 -
Robot-Aided Assessment and Rehabilitation of Upper Extremity Function After Stroke
|
N/A | |
Active, not recruiting |
NCT05520528 -
Impact of Group Participation on Adults With Aphasia
|
N/A | |
Active, not recruiting |
NCT03366129 -
Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
|
||
Completed |
NCT05805748 -
Serious Game Therapy in Neglect Patients
|
N/A | |
Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
Recruiting |
NCT05993221 -
Deconstructing Post Stroke Hemiparesis
|